Karen Akinsanya - Mar 3, 2025 Form 4 Insider Report for Schrodinger, Inc. (SDGR)

Role
President of R&D, Therapeutics
Signature
/s/ Donald Shum, as attorney-in-fact for Karen Akinsanya
Stock symbol
SDGR
Transactions as of
Mar 3, 2025
Transactions value $
$0
Form type
4
Date filed
3/4/2025, 05:29 PM
Previous filing
Jun 17, 2024

Transactions Table

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SDGR Stock Option (right to buy) Award $0 +62.5K $0.00 62.5K Mar 3, 2025 Common Stock 62.5K $21.24 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Grant of restricted stock units ("RSUs") under the Issuer's 2022 Equity Incentive Plan, as amended. Each RSU represents a contingent right to receive one share of common stock of the Issuer. The RSUs were granted on March 3, 2025 and will vest in equal installments on each of March 4, 2026, 2027, 2028 and 2029, subject to the Reporting Person's continued service with the company.
F2 Includes 15,625 unvested RSUs.
F3 The option was granted on March 3, 2025. The shares underlying the option are scheduled to vest with respect to 25% of the shares on March 3, 2026 and the remainder are scheduled to vest in equal monthly installments through March 3, 2029.